Comprehensive characterization of protein–protein interactions perturbed by disease mutations

Feixiong Cheng,Junfei Zhao,Yang Wang,Weiqiang Lu,Zehui Liu,Yadi Zhou,William R. Martin,Ruisheng Wang,Jin Huang,Tong Hao,Hong Yue,Jing Ma,Yuan Hou,Jessica A. Castrillon,Jiansong Fang,Justin D. Lathia,Ruth A. Keri,Felice C. Lightstone,Elliott Marshall Antman,Raul Rabadan,David E. Hill,Charis Eng,Marc Vidal,Joseph Loscalzo

DOI: https://doi.org/10.1038/s41588-020-00774-y

IF: 30.8

2021-02-08

Nature Genetics

Abstract:Technological and computational advances in genomics and interactomics have made it possible to identify how disease mutations perturb protein–protein interaction (PPI) networks within human cells. Here, we show that disease-associated germline variants are significantly enriched in sequences encoding PPI interfaces compared to variants identified in healthy participants from the projects 1000 Genomes and ExAC. Somatic missense mutations are also significantly enriched in PPI interfaces compared to noninterfaces in 10,861 tumor exomes. We computationally identified 470 putative oncoPPIs in a pan-cancer analysis and demonstrate that oncoPPIs are highly correlated with patient survival and drug resistance/sensitivity. We experimentally validate the network effects of 13 oncoPPIs using a systematic binary interaction assay, and also demonstrate the functional consequences of two of these on tumor cell growth. In summary, this human interactome network framework provides a powerful tool for prioritization of alleles with PPI-perturbing mutations to inform pathobiological mechanism- and genotype-based therapeutic discovery.

genetics & heredity

What problem does this paper attempt to address?

The paper primarily explores the impact of disease-related mutations on protein-protein interaction (PPI) networks and investigates the potential applications of these impacts in precision medicine. Specifically, the study addresses the following key issues:

1. **Understanding the functional consequences of variations**: Although the human genome sequencing project has identified a large number of genetic variations, our current understanding of the specific functions and biological consequences of these variations remains limited.

2. **Impact of variations on protein-protein interactions**: By analyzing the enrichment of disease-related mutations at protein-protein interaction interfaces, the study finds that these mutations often significantly affect interactions between proteins.

3. **Impact of mutations on cancer**: Particularly in cancer, somatic missense mutations are significantly more enriched at protein-protein interaction interfaces than in non-interface regions, suggesting that these mutations may promote tumorigenesis by disrupting protein-protein interactions.

4. **Drug response prediction**: The study further analyzes the association between mutations at protein-protein interaction interfaces and drug sensitivity or resistance, finding that specific mutations at these interfaces can serve as biomarkers for predicting patient responses to certain drugs.

5. **Survival rate correlation**: The study also examines the relationship between specific mutations at protein-protein interaction interfaces and patient survival rates, discovering that certain mutations are significantly associated with poorer survival rates.

In summary, by systematically studying mutations at protein-protein interaction interfaces and their distribution across various cancer types, the paper reveals the extensive impact of these mutations on protein networks and their role in disease progression, providing important information for the further development of genotype-based therapeutic strategies.